Ficlatuzumab is a моноклональный антитело (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met рецептор-mediated cancer клетка proliferation, migration, and invasion.
Ficlatuzumab is a monoclonal antibody (McAb) targeting human hepatocyte growth factor (HGF). Ficlatuzumab blocks the activation of the HGF/c-Met signaling pathway, and inhibits c-Met receptor-mediated cancer cell proliferation, migration, and invasion.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.